Blue Trust’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
Blue Trust's XENE Position: Q3 2026 in Review
Blue Trust sold out of Xenon Pharmaceuticals (XENE) in Q3 2026, closing a stake of 724 shares — an estimated $43.7K sold.
Blue Trust first reported a position in XENE in Q4 2022 and held it in 12 quarters. The position peaked at $43.7K in Q2 2026. 196 funds tracked by Wall St. Rank hold XENE as of Q3 2026.
- Blue Trust reported no remaining Xenon Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Blue Trust sold 724 Xenon Pharmaceuticals shares in Q3 2026, an estimated $43.7K.
- Blue Trust first reported a position in Xenon Pharmaceuticals in Q4 2022 and held it in 12 quarters.
- Blue Trust's Xenon Pharmaceuticals position peaked at $43.7K in Q2 2026.
- 196 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.